BioCryst Pharmaceuticals
BCRX
#4731
Rank
NZ$2.77 B
Marketcap
$13.39
Share price
2.44%
Change (1 day)
46.28%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.58 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has NZ$0.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioCryst Pharmaceuticals - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.61 B-7.96%
2022-12-31NZ$0.66 B-10.07%
2021-12-31NZ$0.74 B78.52%
2020-12-31NZ$0.41 B105.8%
2019-12-31NZ$0.20 B29.88%
2018-12-31NZ$0.15 B-3.31%
2017-12-31NZ$0.16 B104.16%
2016-12-31NZ$78.89 M4.72%
2015-12-31NZ$75.33 M-18.89%
2014-12-31NZ$92.87 M100.56%
2013-12-31NZ$46.3 M7.01%
2012-12-31NZ$43.27 M-19.04%
2011-12-31NZ$53.45 M-23.55%
2010-12-31NZ$69.92 M-26.36%
2009-12-31NZ$94.94 M-10.45%
2008-12-31NZ$0.10 B60.19%
2007-12-31NZ$66.18 M24.48%
2006-12-31NZ$53.16 M-27.69%
2005-12-31NZ$73.53 M126.43%
2004-12-31NZ$32.47 M5.41%
2003-12-31NZ$30.81 M-34.05%
2002-12-31NZ$46.71 M-39.36%
2001-12-31NZ$77.03 M38.57%
2000-12-31NZ$55.59 M25.77%
1999-12-31NZ$44.2 M89.39%
1998-12-31NZ$23.33 M256.42%
1997-12-31NZ$6.54 M28.51%
1996-12-31NZ$5.09 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.38 B 137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.11 B 263.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.83 M-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.60 B 175.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.90 B 1,426.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.33 B 129.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.60 B 1,202.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$0.26 B-54.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.68 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA